ecancer

Androgen blockade and ipilimumab against castration resistant prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Paris, France

3 Oct 2013

Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy

30 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France

29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France

29 Sep 2013

Refresher course in prostate cancer treatment

Dr Marc Roach - University of California, USA

15 Aug 2013

Targeting and inhibiting IKK-alpha in prostate cancer

Dr Simon Mackay - University of Strathclyde, Scotland, UK

25 Jul 2013

Establishing immunotherapy as a standard in cancer treatment

Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA

18 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

The problem of unnecessary treatment of prostate cancer

Dr Rosalind Eeles - Royal Marsden Hospital, London, UK

3 Jun 2013

Racial disparities in cancer outcomes

Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA

19 Apr 2013

More from ecancer